Cargando…
Study protocol for a cluster-randomised controlled trial of an NCD access to medicines initiative: evaluation of Novartis Access in Kenya
INTRODUCTION: Novartis recently launched Novartis Access, an initiative to provide a basket of reduced price medicines for non-communicable diseases (NCDs) to be sold through the public and private non-profit sectors in programme countries. This study will evaluate the impact of Novartis Access on t...
Autores principales: | Rockers, Peter C, Wirtz, Veronika J, Vian, Taryn, Onyango, Monica A, Ashigbie, Paul G, Laing, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5168521/ https://www.ncbi.nlm.nih.gov/pubmed/27888177 http://dx.doi.org/10.1136/bmjopen-2016-013386 |
Ejemplares similares
-
Perceptions of Kenyan adults on access to medicines for non-communicable diseases: A qualitative study
por: Onyango, Monica Adhiambo, et al.
Publicado: (2018) -
Availability and prices of medicines for non-communicable diseases at health facilities and retail drug outlets in Kenya: a cross-sectional survey in eight counties
por: Ashigbie, Paul G, et al.
Publicado: (2020) -
Equity in access to non-communicable disease medicines: a cross-sectional study in Kenya
por: Rockers, Peter C, et al.
Publicado: (2018) -
Household access to non-communicable disease medicines during universal health care roll-out in Kenya: A time series analysis
por: Kiragu, Zana Wangari, et al.
Publicado: (2022) -
Coping with access barriers to non‐communicable disease medicines: qualitative patient interviews in eight counties in Kenya
por: Ng, Gloria, et al.
Publicado: (2021)